Columbia University Irving Medical Center — New York, New York

Public research footprint of Columbia University Irving Medical Center, compiled from the ClinicalTrials.gov public registry.

687

Registered studies

369

Active

234

Recruiting now

227

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Solid Tumors · GBM · Glioma

Recently updated registry entries

NCT05063565 — TheraSphere With Durvalumab and Tremelimumab for HCC (Active Not Recruiting)
NCT06007690 — A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of… (Active Not Recruiting)
NCT06430086 — Mechanistic Effect of Walnut Consumption on Sleep Quality (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Columbia University Irving Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.